One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients—a pilot study
Open Access
- 3 May 2021
- journal article
- research article
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 25 (12) , 6707-6715
Abstract
Objectives: The aim of the study was to compare the performance of narrow diameter implants in patients with uncontrolled diabetes mellitus type 2 (T2DM) and normo-glycemic individuals during the first 12 months after implant loading. Material and methods: In 16 T2DM patients with HbA1C > 6.5% (test group) and 16 normo-glycemic patients (HbA1C < 6.0%; control group), one to two narrow diameter tissue level implants were placed in the posterior maxilla or mandible. After 3-month lasting integration period, implants were loaded by fixed dentures. The clinical parameters probing depth (PD), bleeding on probing (BOP), attachment loss (CAL), recession and papilla bleeding index (PBI) were assessed manually at loading and after 12 months of function. The paired digital periapical radiographs were analyzed with regard to the change in marginal bone level (MBL) from baseline to 12 months’ control. The mean values calculated for both patient groups were statistically analyzed. The technical complications were recorded. Results: The T2DM group accounted 13 patients due to 3 dropouts. The overall implant survival rate after 12 months was 100%. The differences in means for the clinical parameters and the MBL were statistically non-significant between the T2DM and normo-glycemic patients for the short period of loaded function reported here. No technical complications were recorded. Conclusions: The study demonstrated an encouraging clinical outcome with narrow diameter implants in patients with uncontrolled T2DM compared to non-diabetics after 12 months post loading. For the short observation period, no biological and technical complications were reported regardless the glycemic status. Clinical relevance: Patients with HbA1C > 6.5% may benefit from the treatment with narrow diameter implants by avoiding complex surgical interventions with augmentation procedures. Trial registration: Clinicaltrials.gov: NCT04630691Keywords
Funding Information
- Straumann AG
This publication has 36 references indexed in Scilit:
- A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium AlloyJournal of Oral Implantology, 2015
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2013
- Executive Summary: Standards of Medical Care in Diabetes—2014Diabetes Care, 2013
- Long‐Term Outcomes of Dental Implants with a Titanium Plasma‐Sprayed Surface: A 20‐Year Prospective Case Series Study in Partially Edentulous PatientsClinical Implant Dentistry and Related Research, 2013
- Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow‐up of 5 yearsClinical Oral Implants Research, 2012
- A systematic review on survival and success rates of implants placed immediately into fresh extraction sockets after at least 1 yearClinical Oral Implants Research, 2011
- Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 Diabetes mellitus – a randomized controlled trialClinical Oral Implants Research, 2011
- Osseointegration of SLActive implants in diabetic pigsClinical Oral Implants Research, 2011
- Mechanical properties of the binary titanium‐zirconium alloys and their potential for biomedical materialsJournal of Biomedical Materials Research, 1995
- Tissue integration of non‐submerged implants. l‐year results of a prospective study with 100 ITI hollow‐cylinder and hollow‐screw implants.Clinical Oral Implants Research, 1990